CTI BIOPHARMA CORP COMMON STOCK (CTIC) Covered Calls

You can sell covered calls on CTI BIOPHARMA CORP COMMON STOCK to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CTIC (prices last updated Mon 4:16 PM ET):

CTI BIOPHARMA CORP COMMON STOCK (CTIC) Stock Quote

Last

Change

Bid

Ask

Volume

P/E

Market Cap

1.65

-0.04

1.62

1.71

93K

-

0.1B

Covered Calls For CTI BIOPHARMA CORP COMMON STOCK (CTIC)

Expiration

Strike

Call Bid

Net Debit

ReturnIf Flat

AnnualizedReturn If Flat

Dec 21

2

0.10

1.61

6.2%

68.6%

Jan 18

2

0.00

1.71

0.0%

0.0%

Subscribers get access to the full covered call chain, and more features.

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.